Bill Snyder

March 14, 2019

New way to stimulate learning?

Vagus nerve stimulation could be beneficial for treating Alzheimer’s disease and other forms of cognitive impairment, Vanderbilt research findings suggest.

By Bill Snyder
March 14, 2019

Germ cell biology expert Lehmann set for March 21 Discovery Lecture

Ruth Lehmann, PhD, a world-renowned expert on the biology of germ cells, which generate eggs and sperm, will deliver the next Flexner Discovery Lecture on Thursday, March 21.

By Bill Snyder
March 7, 2019

Vanderbilt scientists report new modeling of brain signaling

The release of neurotransmitters and hormones in the body is tightly controlled by complex protein machinery embedded in cell membranes.

By Bill Snyder
February 28, 2019

Gene identified that increases risk of antibiotic reaction

Researchers at Vanderbilt University Medical Center and colleagues have identified a gene that increases the risk for a severe and potentially life-threatening reaction to the commonly prescribed antibiotic vancomycin.

By Bill Snyder
February 21, 2019

VUMC chikungunya antibody set to enter clinical trial

A monoclonal antibody against the chikungunya virus developed by researchers at Vanderbilt University Medical Center is the first monoclonal antibody encoded by messenger RNA to enter a clinical trial.

By Bill Snyder
February 14, 2019

Stanford’s Minor set for Feb. 21 Discovery Lecture

Lloyd Minor, MD, the Carl and Elizabeth Naumann Dean of the Stanford University School of Medicine, will discuss “Digitally Driven: Health Care in the Era of Precision Health,” during a Flexner Discovery Lecture on Thusday, Feb. 21.

By Bill Snyder
February 13, 2019

Researchers push forward frontiers of vaccine science

Using sophisticated gene sequencing and computing techniques, researchers at Vanderbilt University Medical Center and the San Diego Supercomputer Center have achieved a first-of-its-kind glimpse into how the body’s immune system gears up to fight off infection.
By Bill Snyder
February 7, 2019

Vanderbilt Prize lecturer Amon driven to solve genetic mysteries

For much of her career, Angelika Amon, PhD, recipient of the 2018 Vanderbilt Prize in Biomedical Science, has pursued a mystery with life-or-death consequences.
By Bill Snyder
January 31, 2019

Destructive ‘telegrams’ in asthma

Vanderbilt investigators have discovered that certain microRNAs — "telegram"-like signals — increase after the induction of allergic airway inflammation.
By Bill Snyder
January 31, 2019

Designing antibodies to fight the flu

Vanderbilt investigators said their work shows that computational design can improve the ability of naturally occurring antibodies to recognize different flu strains and may hasten the development of more effective flu therapies and vaccines.
By Bill Snyder
January 31, 2019

Research bolsters thyroid function, atrial fibrillation link

A study by researchers at Vanderbilt University Medical Center has strengthened the link between thyroid function and atrial fibrillation (AF), an irregular heart rhythm that increases the risk of stroke and other heart-related complications.
By Bill Snyder
January 24, 2019

Vanderbilt Prize winner Amon to speak at Jan. 31 lecture

Angelika Amon, PhD, recipient of the 2018 Vanderbilt Prize in Biomedical Science, will deliver her Vanderbilt Prize lecture at 4 p.m. Thursday, Jan. 31, in 208 Light Hall.
By Bill Snyder